Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2020/8811798 http://scihub22266oqcxt.onion/10.1155/2020/8811798 33425407!7771254!33425407     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Case+Rep+Infect+Dis 2020 ; 2020 (ä): 8811798 Nephropedia Template TP {{tp|p=33425407|t=2020. The Safe Administration of Remdesivir in a Patient with Acute Kidney Injury Requiring Hemodialysis |pdf=|usr=}}{{33425407}} gab.com Text The Safe Administration of Remdesivir in a Patient with Acute Kidney Injury Requiring Hemodialysis JO: Case Rep Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33425407 #FOAvip Remdesivir is a nucleoside analog prodrug with broad-spectrum antiviral activity, including against coronaviruses. This has prioritized the inclusion of remdesivir in coronavirus disease 2019 (COVID-19) clinical trials. The United States Food and Drug Administration has granted emergency use authorization for remdesivir. This emergency use authorization does not recommend the use of remdesivir in patients with estimated glomerular filtration rate (eGFR) less than 30 mL/min unless the benefits outweigh the risks. To date, there are no studies and scant information in the literature evaluating remdesivir utilization in patients with eGFR less than 30 mL/min or receiving hemodialysis. With little utilization data for patients with acute or chronic kidney injury, remdesivir may not be considered, leaving this patient population without the opportunity of a potentially beneficial treatment option. We present a case of one patient with eGFR less than 30 mL/min that required hemodialysis in which remdesivir was safely initiated, with therapy completed without any serious adverse events. Twit Text FOAVip The Safe Administration of Remdesivir in a Patient with Acute Kidney Injury Requiring Hemodialysis ????Case Rep Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33425407 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33425407 #FOAvip English Wikipedia <ref>{{Cite pmid|33425407}}</ref> The Safe Administration of Remdesivir in a Patient with Acute Kidney Injury Requiring Hemodialysis #MMPMID33425407 Peyko V; Ladd H; Cutrona A Case Rep Infect Dis 2020[]; 2020 (ä): 8811798 PMID33425407show ga Remdesivir is a nucleoside analog prodrug with broad-spectrum antiviral activity, including against coronaviruses. This has prioritized the inclusion of remdesivir in coronavirus disease 2019 (COVID-19) clinical trials. The United States Food and Drug Administration has granted emergency use authorization for remdesivir. This emergency use authorization does not recommend the use of remdesivir in patients with estimated glomerular filtration rate (eGFR) less than 30 mL/min unless the benefits outweigh the risks. To date, there are no studies and scant information in the literature evaluating remdesivir utilization in patients with eGFR less than 30 mL/min or receiving hemodialysis. With little utilization data for patients with acute or chronic kidney injury, remdesivir may not be considered, leaving this patient population without the opportunity of a potentially beneficial treatment option. We present a case of one patient with eGFR less than 30 mL/min that required hemodialysis in which remdesivir was safely initiated, with therapy completed without any serious adverse events. äThe Safe Administration of Remdesivir in a Patient with Acute Kidney I(epmc).pdf DeepDyve Pubget Overpricing